Cleared Traditional

K242339 - Intravascular Extension Sets and Access...

K242339 is the FDA 510(k) clearance for Intravascular Extension Sets and Access... by Baxter Healthcare Corporation. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 205-day FDA review.

K242339 · Baxter Healthcare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2025
Decision
205d
Days
Class 2
Risk

K242339 is an FDA 510(k) clearance for the Intravascular Extension Sets and Accessories. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on February 28, 2025 after a review of 205 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K242339 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2024
Decision Date February 28, 2025
Days to Decision 205 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d slower than avg
Panel avg: 129d · This submission: 205d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 445
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K242339.
SteadiSet Infusion Set
K242692 · Capillary Biomedical, LLC · May 2025
JetCan® Pro Safety Huber Needle
K242763 · Pfm Medical, Inc. · May 2025
Solution Administration Sets
K243529 · Baxter Healthcare Corporation · Mar 2025
Lyka® PORT Needle Free Access Device (4170Y)
K241058 · Quest Medical, Inc. · Dec 2024
Ecomed Disposable Administration Sets
K234129 · Ecomed Solutions, LLC · Sep 2024
I.V. Administration Set
K242126 · Bq Plus Medical Co., Ltd. · Aug 2024